# POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

> **NCT07469722** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 128 (estimated)

## Conditions studied

- Acute Heart Failure (AHF)
- Congestive Heart Failure Acute
- Diuretic Effect
- Lung Ultrasonography Score
- Ultrasonography, Doppler
- Point-of-care Ultrasound (POCUS)

## Interventions

- **DRUG:** Furosemide 40 Milligrams.
- **DRUG:** Furosemide 40 Milligrams.
- **DRUG:** Hydrochlorothiazide (HCTZ) 25 milligrams.
- **DRUG:** Acetazolamide 250 milligrams.
- **DRUG:** Dapagliflozin (10mg Tab)
- **DRUG:** Potassium Chloride Oral Product

## Key facts

- **NCT ID:** NCT07469722
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-07-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469722, "POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07469722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*